Skip to content
← Full study record

NCT01730586 · MORE INFO

Limitations, agreements, and source contact

Abraxane in CIMP-High Colorectal and Small Bowel Adenocarcinomas · Source last updated 2020-01-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
MOverman@mdanderson.org
organization
The University of Texas (UT) MD Anderson Cancer Center
phone
713-792-7734
title
Dr. Michael Overman, Associate Professor, GI Medical Oncology
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
MOverman@mdanderson.org
organization
The University of Texas (UT) MD Anderson Cancer Center
phone
713-792-7734
title
Dr. Michael Overman, Associate Professor, GI Medical Oncology

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice